OpenVSafe by OpenVAERS
Search V-safe

CTF-86333-44537

3 vaccinations 1 coded response 6 check-ins 1 free-text entry 1 call case
Sex
Female
Age at first dose
31-35
ZIP prefix
688 / NE
Registered
2021-12-08
Relationship
Self
Race
N/A
Ethnicity
Hispanic or Latino

Timeline

  1. 2021-03-17
    Dose 1 — Pfizer-BioNTech
  2. 2021-04-07
    Dose 2 — Pfizer-BioNTech
  3. 2021-12-07
    Dose 3 — Pfizer-BioNTech
  4. 2021-12-08
    Registered in v-safe
  5. 2021-12-08
    Health check-in — days 1–6 daily, dose 3
    Feeling: Poor · Site: Pain · Fever · Headache, Joint pains, Muscle or body aches, Nausea, Vomiting, Abdominal pain · Be unable to do your normal daily activities
    Adult check-in
  6. 2021-12-09
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Site: Pain · Muscle or body aches
    Adult check-in
  7. 2021-12-10
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Headache
    Adult check-in
  8. 2021-12-11
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Headache · Be unable to do your normal daily activities
    Adult check-in
  9. 2021-12-13
    Health check-in — days 1–6 daily, dose 3
    Feeling: Fair · Fatigue or tiredness
    Adult check-in
  10. 2022-01-20
    Survey response — day 42, dose 3
    MedDRA: Cough, Nasal congestion, Oropharyngeal pain, Unevaluable event — Feeling: Poor · Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Outpatient clinic or urgent care clinic visit
    Free text: Tos, dolor de garganta, congestión nasal y temperatura
    MedDRA releases: 2024-11 · check-in free text available
  11. 2022-01-20
    Report sent to call center — day 42, dose 3
    Be unable to do your normal daily activities · Get care from a doctor or other healthcare professional
    Outpatient clinic or urgent care clinic visit · 1 call case(s)
  12. 2022-01-21
    Call successful
    Not applicable (accidental reporting or does not believe symptoms are related to vaccine)

Vaccinations

DoseDateManufacturerCo-administered
12021-03-17Pfizer-BioNTech No
22021-04-07Pfizer-BioNTech No
32021-12-07Pfizer-BioNTech No

Call center

1 call center case

1 successful

See the call center timeline

Free text

Release 10 — day 42, dose 3

2022-01-20

Symptoms: Tos, dolor de garganta, congestión nasal y temperatura

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDCough · · ✓
SDNasal congestion · · ✓
SDOropharyngeal pain · · ✓
SDUnevaluable event · · ✓

✓ active code · ○ coded but marked inactive · blank = not in that release